Publication | Open Access
Tenofovir disoproxil fumarate/emtricitabine and severity of coronavirus disease 2019 in people with HIV infection
20
Citations
30
References
2022
Year
Compared with other antiretrovirals, TDF/FTC lowers COVID-19 severity among HIV-positive individuals with virological control. This protective effect may be restricted to individuals aged 50 years and older.
| Year | Citations | |
|---|---|---|
Page 1
Page 1